Uganda set to launch Lenacapavir Injectable PrEp at Lira Regional Referral Hospital.

Uganda is taking a giant leap towards an HIV-free generation. This Friday, the country will launch Lenacapavir, a long-acting injectable drug for HIV prevention, administered twice yearly.The launch event will take place at Lira Regional Referral Hospital by the Minister of health Jane Ruth Aceng, under the theme “Expanding HIV Prevention Choices with Lenacapavir: A bold step towards an HIV-free generation.”Lenacapavir has shown near 100 per cent effectiveness in preventing HIV infection in clinical trials, making it a powerful tool in the fight against HIV/Aids.The drug will be administered to high-risk populations, including adolescent girls and young women, pregnant and breastfeeding mothers, female sex workers, and their male clients.Dr. Andrew Odur, the director of Lira Regional Referral Hospital, who confirmed the development, said the drug will only be administered to those who are HIV negative.